Salma Moona Alam

Closest collaborators

The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Yuk Ting Ma · 2 shared papers, 2018–2019 · strength 0.19
   • Paper Gemcitabine-Induced Cardiotoxicity in Patients Receiving Adjuvant Chemotherapy for Pancreatic Cancer: A Case Series. DOI 10.1159/000488139↗
   • Paper Impact of intensified chemotherapy in metastatic pancreatic ductal adenocarcinoma (PDAC) in clinical routine in Europe. DOI 10.1016/j.pan.2018.10.003↗
2. Pankaj Punia · 1 shared paper, 2018 · strength 0.12
   • Paper Gemcitabine-Induced Cardiotoxicity in Patients Receiving Adjuvant Chemotherapy for Pancreatic Cancer: A Case Series. DOI 10.1159/000488139↗
3. Marvin Schober · 1 shared paper, 2019 · strength 0.07
   • Paper Impact of intensified chemotherapy in metastatic pancreatic ductal adenocarcinoma (PDAC) in clinical routine in Europe. DOI 10.1016/j.pan.2018.10.003↗
4. Ángela Lamarca · 1 shared paper, 2019 · strength 0.07
   • Paper Impact of intensified chemotherapy in metastatic pancreatic ductal adenocarcinoma (PDAC) in clinical routine in Europe. DOI 10.1016/j.pan.2018.10.003↗
5. Patrick Maisonneuve · 1 shared paper, 2019 · strength 0.07
   • Paper Impact of intensified chemotherapy in metastatic pancreatic ductal adenocarcinoma (PDAC) in clinical routine in Europe. DOI 10.1016/j.pan.2018.10.003↗
6. Daniel H. Palmer · 1 shared paper, 2019 · strength 0.07
   • Paper Impact of intensified chemotherapy in metastatic pancreatic ductal adenocarcinoma (PDAC) in clinical routine in Europe. DOI 10.1016/j.pan.2018.10.003↗
7. Muhammad Ahsan Javed · 1 shared paper, 2019 · strength 0.07
   • Paper Impact of intensified chemotherapy in metastatic pancreatic ductal adenocarcinoma (PDAC) in clinical routine in Europe. DOI 10.1016/j.pan.2018.10.003↗
8. Sebastian Krug · 1 shared paper, 2019 · strength 0.07
   • Paper Impact of intensified chemotherapy in metastatic pancreatic ductal adenocarcinoma (PDAC) in clinical routine in Europe. DOI 10.1016/j.pan.2018.10.003↗
9. Nha Ngoc Hoa Le · 1 shared paper, 2019 · strength 0.07
   • Paper Impact of intensified chemotherapy in metastatic pancreatic ductal adenocarcinoma (PDAC) in clinical routine in Europe. DOI 10.1016/j.pan.2018.10.003↗
10. Lívia Archibugi · 1 shared paper, 2019 · strength 0.07
    • Paper Impact of intensified chemotherapy in metastatic pancreatic ductal adenocarcinoma (PDAC) in clinical routine in Europe. DOI 10.1016/j.pan.2018.10.003↗
11. Malin Sund · 1 shared paper, 2019 · strength 0.07
    • Paper Impact of intensified chemotherapy in metastatic pancreatic ductal adenocarcinoma (PDAC) in clinical routine in Europe. DOI 10.1016/j.pan.2018.10.003↗
12. Gabriele Capurso · 1 shared paper, 2019 · strength 0.07
    • Paper Impact of intensified chemotherapy in metastatic pancreatic ductal adenocarcinoma (PDAC) in clinical routine in Europe. DOI 10.1016/j.pan.2018.10.003↗
13. Albrecht Neeße · 1 shared paper, 2019 · strength 0.07
    • Paper Impact of intensified chemotherapy in metastatic pancreatic ductal adenocarcinoma (PDAC) in clinical routine in Europe. DOI 10.1016/j.pan.2018.10.003↗
14. Georg Beyer · 1 shared paper, 2019 · strength 0.07
    • Paper Impact of intensified chemotherapy in metastatic pancreatic ductal adenocarcinoma (PDAC) in clinical routine in Europe. DOI 10.1016/j.pan.2018.10.003↗
15. Richard A Hubner · 1 shared paper, 2019 · strength 0.07
    • Paper Impact of intensified chemotherapy in metastatic pancreatic ductal adenocarcinoma (PDAC) in clinical routine in Europe. DOI 10.1016/j.pan.2018.10.003↗
16. Juan W. Valle · 1 shared paper, 2019 · strength 0.07
    • Paper Impact of intensified chemotherapy in metastatic pancreatic ductal adenocarcinoma (PDAC) in clinical routine in Europe. DOI 10.1016/j.pan.2018.10.003↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.